7 research outputs found
Sociodemographic and sexual risk factors associated with ever being HIV-tested among female respondents, ZDHS 2010–11.
<p>Sociodemographic and sexual risk factors associated with ever being HIV-tested among female respondents, ZDHS 2010–11.</p
Sociodemographic and sexual risk factors associated with ever being HIV-tested among male respondents, ZDHS 2010–11.
<p>Sociodemographic and sexual risk factors associated with ever being HIV-tested among male respondents, ZDHS 2010–11.</p
Projected impact of the VMMC program over 2016–2030, with VMMC scale-up embedded within broader scale-up of HIV prevention and treatment, according to the global Fast Track targets, evaluated relative to the counterfactual scenario in which the Fast Track targets for other interventions are met without VMMC.
<p>Projected impact of the VMMC program over 2016–2030, with VMMC scale-up embedded within broader scale-up of HIV prevention and treatment, according to the global Fast Track targets, evaluated relative to the counterfactual scenario in which the Fast Track targets for other interventions are met without VMMC.</p
Sensitivity analyses.
<p>Impact and cost-effectiveness of Zimbabwe’s VMMC program under alternative assumptions for key parameters whose values are uncertain.</p
Projected impact, costs and savings from the VMMC program in a 'status quo' background context, relative to the counterfactual scenario of no VMMC program ever.
<p>Projected impact, costs and savings from the VMMC program in a 'status quo' background context, relative to the counterfactual scenario of no VMMC program ever.</p
Modeled circumcisions.
<p><b>(A) Number of new VMMCs occurring each year and (B) the resulting percentage of men ages 15–49 who are circumcised, by scenario.</b> The 2009–2016 new VMMCs are from program data; the 2008–2009 circumcision coverage was the modelers’ estimate based on the 2005 and 2010 DHS. The projected results (VMMC numbers and circumcision coverage over 2010–2030) shown here are from the Goals model; the ICL and EMOD models projected similar numbers (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0199453#pone.0199453.t002" target="_blank">Table 2</a>) and coverages (not shown).</p